Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Upgrade
/Free Sign Up
 0
🧠 Watchlist Wednesday: Copy Legendary Investors' Portfolios in One Click COPY FOR FREE
Close

Novozymes A/S B (NVZMF)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
67.8500 -1.2410    -1.80%
10/09 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 432
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 67.8500 - 67.8500
Novozymes B 67.8500 -1.2410 -1.80%

NVZMF Income Statement

 
Featured here, the Income Statement (earnings report) for Novozymes A/S B, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Collapse All
Period Ending: 2024
30/06
 2024
31/03
 2023
31/12
 2023
30/09
Total Revenue 915.85 915.85 4603 4456
Revenue 915.85 915.85 4603 4456
Other Revenue, Total - - - -
Cost of Revenue, Total 532.35 532.35 2118 2058
Gross Profit 383.5 383.5 2485 2398
Total Operating Expenses 804.1 804.1 3535 3272
Selling/General/Admin. Expenses, Total 179.75 179.75 843 767
Research & Development 97.25 97.25 524 461
Depreciation / Amortization - - -1024 332
Interest Expense (Income) - Net Operating -21.7 -21.7 -120 -34
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 16.45 16.45 1194 -312
Operating Income 111.75 111.75 1068 1184
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - 75 -
Other, Net 66.75 66.75 70 36
Net Income Before Taxes 45 45 923 1148
Provision for Income Taxes 13.05 13.05 228 219
Net Income After Taxes 31.95 31.95 695 929
Minority Interest 1.5 1.5 373 406
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 31.95 31.95 698 936
Total Extraordinary Items - - - -
Net Income 31.95 31.95 698 936
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 31.95 31.95 698 936
Dilution Adjustment - - -0.931 0.151
Diluted Net Income 31.95 31.95 698.93 935.85
Diluted Weighted Average Shares 277.9 277.9 278.4 277.7
Diluted EPS Excluding Extraordinary Items 0.115 0.115 2.51 3.37
DPS - Common Stock Primary Issue 0.134 0.134 - 4.2
Diluted Normalized EPS 0.201 0.201 2.27 2.7
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NSISb Comments

Write your thoughts about Novozymes A/S
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Apple
Continue with Google
or
Sign up with Email